Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01060540 · ClinicalTrials.gov registry record · NA
Genetic Testing for Type 2 Diabetes
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 601
- Enrollment target
NCT01060540: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT01060540 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 601 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01060540, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 601 participants
- Enrollment target
Study Summary
In this 6-month randomized, controlled trial, we examined whether providing participants with genetic test results and counseling regarding their risk for type 2 diabetes would motivate them to improve their health behaviors and lose weight to reduce their diabetes risk. We hypothesized that participants who received conventional diabetes counseling plus genetic test results and counseling would have at least 6 lb greater weight loss at 3 months than participants who received conventional diabetes counseling without genetic test results.
Primary Outcome
weight 3 months post-enrollment
Interventions
- GENETIC genetic testing for type 2 diabetes
- BEHAVIORAL Conventional risk counseling
- BEHAVIORAL eye disease counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 601 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT01060540 record still lists
NCT01060540 is an interventional study that assigns participants to a tested intervention. The registered 601 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 3 interventions - of which genetic testing for type 2 diabetes is the first listed.
NCT01060540 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01060540 about?
NCT01060540 is a clinical study titled "Genetic Testing for Type 2 Diabetes". In this 6-month randomized, controlled trial, we examined whether providing participants with genetic test results and counseling regarding their risk for type 2 diabetes would motivate them to improve their health behaviors and lose weight to reduce their diabetes risk. We hypothesized that partici...
What is the current status of trial NCT01060540?
This trial is currently completed. It is a NA study. The enrollment target is 601 participants. The study started on 2010-08. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01060540?
The interventions under investigation include: genetic testing for type 2 diabetes (GENETIC), Conventional risk counseling (BEHAVIORAL), eye disease counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01060540?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01060540's enrollment target sits among peer trials
601 162nd of 2000 higher than 1,839 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia